{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:23:09Z","timestamp":1788121389401,"version":"build-2803163510"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.biopha.2022.112727","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:59:03Z","timestamp":1645685943000},"page":"112727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Autophagy and cancer: Can tetrandrine be a potent anticancer drug in the near future?"],"prefix":"10.1016","volume":"148","author":[{"given":"N.","family":"Bhagya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.","family":"Chandrashekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112727_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.578418","article-title":"The double-edge sword of autophagy in cancer: from tumor suppression to pro-tumor activity","volume":"10","author":"Chavez-Dominguez","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.112727_bib2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-019-0474-7","article-title":"Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients","volume":"27","author":"Mulcahy Levy","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2022.112727_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"issue":"2018","key":"10.1016\/j.biopha.2022.112727_bib4","article-title":"Autophagy modulation in cancer: current knowledge on action and therapy","author":"Marinkovi\u0107","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2022.112727_bib5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI20039","article-title":"Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene","volume":"112","author":"Qu","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.112727_bib6","doi-asserted-by":"crossref","first-page":"15077","DOI":"10.1073\/pnas.2436255100","article-title":"Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor","volume":"100","author":"Yue","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.112727_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/geno.1999.5851","article-title":"Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21","volume":"59","author":"Aita","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.biopha.2022.112727_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/45257","article-title":"Induction of autophagy and inhibition of tumorigenesis by beclin 1","volume":"402","author":"Liang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.112727_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/462658","article-title":"Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer","volume":"2014","author":"Valente","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2022.112727_bib10","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1101\/gad.287524.116","article-title":"Recent insights into the function of autophagy in cancer","volume":"30","author":"Amaravadi","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2022.112727_bib11","article-title":"Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112727_bib12","first-page":"105","article-title":"Autophagy enhances the aggressiveness of human colorectal cancer cells and their ability to adapt to apoptotic stimulus","volume":"9","author":"Zheng","year":"2012","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.biopha.2022.112727_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2019.00114","article-title":"Transcriptional regulation of autophagy: mechanisms and diseases","volume":"7","author":"Di Malta","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib14","doi-asserted-by":"crossref","first-page":"7410","DOI":"10.1038\/sj.onc.1209086","article-title":"FOXO transcription factors at the interface between longevity and tumor suppression","volume":"24","author":"Greer","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.112727_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102752","article-title":"Autophagy and the lysosomal system in cancer","volume":"10","author":"Kumar","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2022.112727_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13020-020-00402-1","article-title":"Transcription factor EB agonists from natural products for treating human diseases with impaired autophagy-lysosome pathway","volume":"15","author":"Xu","year":"2020","journal-title":"Chin. Med."},{"key":"10.1016\/j.biopha.2022.112727_bib17","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1242\/jcs.146365","article-title":"TFEB at a glance","volume":"129","author":"Napolitano","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2022.112727_bib18","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798804","article-title":"The complex relationship between TFEB transcription factor phosphorylation and subcellular localization","volume":"37","author":"Puertollano","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2022.112727_bib19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112727_bib20","doi-asserted-by":"crossref","first-page":"39107","DOI":"10.1074\/jbc.M112.412569","article-title":"The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism","volume":"287","author":"Xiong","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.112727_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncb2069","article-title":"Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity","volume":"12","author":"Zhao","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2019.01614","article-title":"Phytochemicals in cancer treatment: from preclinical studies to clinical practice","volume":"10","author":"Choudhari","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112727_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2021.639628","article-title":"Phytochemicals as a complement to cancer chemotherapy: pharmacological modulation of the autophagy-apoptosis pathway","volume":"12","author":"Rahman","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112727_bib24","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1021\/np50101a020","article-title":"Bisbenzylisoquinoline alkaloids from Cyclea barbata","volume":"56","author":"Guinaudeau","year":"1993","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2022.112727_bib25","first-page":"499","article-title":"Effect of Cyclea peltata Lam. roots aqueous extract on glucose levels, lipid profile, insulin, TNF-\u03b1 and skeletal muscle glycogen in type 2 diabetic rats","volume":"48","author":"Kirana","year":"2010","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib26","first-page":"392","article-title":"Targeted isolation of alkaloid from Cyclea peltata and determination of structural formula of tetrandrine alkaloid based on NMR studies","volume":"2","author":"Pillai","year":"2010","journal-title":"Int. J. Phytomed."},{"key":"10.1016\/j.biopha.2022.112727_bib27","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1021\/jo00950a016","article-title":"New alkaloids and related artifacts from Cycled peltata","volume":"38","author":"Kupchan","year":"1973","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.biopha.2022.112727_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF00567175","article-title":"Alkaloids of Stephania hernandifolia. III","volume":"3","author":"Fadeeva","year":"1967","journal-title":"Chem. Nat. Compd."},{"key":"10.1016\/j.biopha.2022.112727_bib29","doi-asserted-by":"crossref","unstructured":"K.K. Chen, A.L. Chen, The Alkaloids of Han-Fang-Chi, 109, 1935, pp. 1\u20134.","DOI":"10.1016\/S0021-9258(18)75199-5"},{"key":"10.1016\/j.biopha.2022.112727_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phytochem.2016.02.005","article-title":"Tetrandrine \u2013 a molecule of wide bioactivity","volume":"125","author":"Bhagya","year":"2016","journal-title":"Phytochemistry"},{"key":"10.1016\/j.biopha.2022.112727_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s40011-021-01246-x","article-title":"In vitro production of tetrandrine from Callus culture of Cyclea peltata hook f. thoms","author":"Bhagya","year":"2021","journal-title":"Proc. Natl. Acad. Sci. India Sect. B Biol. Sci."},{"key":"10.1016\/j.biopha.2022.112727_bib32","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1080\/14786419.2018.1503660","article-title":"Optimization of column chromatography technique for the isolation of tetrandrine from Cyclea peltata and LC-ESI-MS based quantification and validation of the method","volume":"33","author":"Bhagya","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2022.112727_bib33","doi-asserted-by":"crossref","first-page":"40800","DOI":"10.18632\/oncotarget.8315","article-title":"Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.112727_bib34","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopha.2017.10.116","article-title":"Tetrandrine and cancer \u2013 an overview on the molecular approach","volume":"97","author":"Bhagya","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.112727_bib35","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.21873\/anticanres.13874","article-title":"Tetrandrine increases the sensitivity of human lung adenocarcinoma PC14 cells to gefitinib by lysosomal inhibition","volume":"39","author":"Sato","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2022.112727_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11671-018-2716-x","article-title":"Autophagy inhibitor (LY294002) and 5-fluorouracil (5-FU) combination-based nanoliposome for enhanced efficacy against esophageal squamous cell carcinoma","volume":"13","author":"Feng","year":"2018","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.biopha.2022.112727_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-017-0410-1","article-title":"The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549\/DDP cells and A549 cells","volume":"17","author":"Ye","year":"2017","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2022.112727_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2017.00351","article-title":"Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-\u03b1 inhibition and mTOR-dependent mechanisms","volume":"8","author":"Wong","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2019","key":"10.1016\/j.biopha.2022.112727_bib39","article-title":"Tetrandrine-induced autophagy in MDA-MB-231 triple-negative breast cancer cell through the inhibition of PI3K\/AKT\/mTOR signaling","author":"Guo","year":"2019","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2022.112727_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2014.84","article-title":"Tetrandrine blocks autophagic flux and induces apoptosis via energetic impairment in cancer cells","volume":"5","author":"Qiu","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.112727_bib41","doi-asserted-by":"crossref","first-page":"35576","DOI":"10.1074\/jbc.M112.370585","article-title":"Autophagy-related gene 7 (ATG7) and reactive oxygen species\/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma","volume":"287","author":"Gong","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.112727_bib42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3892\/ijo.2013.1952","article-title":"Tetrandrine induces cell death in SAS human oral cancer cells through caspase activation-dependent apoptosis and LC3-I and LC3-II activation-dependent autophagy","volume":"43","author":"Huang","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2022.112727_bib43","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.18632\/oncotarget.3505","article-title":"Tetrandrine induces autophagy and differentiation by activating ROS and Notch1 signaling in leukemia cells","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.112727_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-3701-5-4","article-title":"Tetrandrine is a potent cell autophagy agonist via activated intracellular reactive oxygen species","volume":"5","author":"Wang","year":"2015","journal-title":"Cell Biosci."},{"key":"10.1016\/j.biopha.2022.112727_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/tox.22053","article-title":"Tetrandrine induces apoptosis Via caspase-8, -9, and -3 and poly (ADP ribose) polymerase dependent pathways and autophagy through beclin-1\/ LC3-I, II signaling pathways in human oral cancer HSC-3 cells","volume":"31","author":"Yu","year":"2016","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.biopha.2022.112727_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189807","article-title":"Targeting autophagy with natural products as a potential therapeutic approach for cancer","volume":"22","author":"Al-Bari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2022.112727_bib47","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/cr.2010.82","article-title":"Overview of macroautophagy regulation in mammalian cells","volume":"20","author":"Mehrpour","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2022.112727_bib48","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","article-title":"Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion","volume":"11","author":"Mauvezin","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2022.112727_bib49","first-page":"1647","article-title":"Autophagy modulation in bladder cancer development and treatment (review)","volume":"42","author":"Li","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2022.112727_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-021-00570-z","article-title":"Is targeting autophagy mechanism in cancer a good approach? The possible double-edge sword effect","volume":"11","author":"Lim","year":"2021","journal-title":"Cell Biosci."},{"issue":"6","key":"10.1016\/j.biopha.2022.112727_bib51","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1042\/EBC20170021","article-title":"The mammalian ULK1 complex and autophagy initiation","volume":"61","author":"Zachari","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.biopha.2022.112727_bib52","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/cr.2013.159","article-title":"A current perspective of autophagosome biogenesis","volume":"24","author":"Shibutani","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2022.112727_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2020478118","article-title":"Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin","volume":"118","author":"Wijshake","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.112727_bib54","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.1021\/jacs.9b12705","article-title":"Beclin 1-ATG14L protein-protein interaction inhibitor selectively inhibits autophagy through disruption of VPS34 complex i","volume":"142","author":"Pavlinov","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2022.112727_bib55","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2022.112727_bib56","first-page":"1","article-title":"Hepatitis B Virus subverts the autophagy elongation complex","volume":"92","author":"Not","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2022.112727_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-01000-2","article-title":"Targeting autophagy to overcome drug resistance: further developments","volume":"13","author":"Chang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2022.112727_bib58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3892\/ijo.2017.4052","article-title":"Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7","volume":"51","author":"Yao","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2022.112727_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/tox.22238","article-title":"Tetrandrine induces programmed cell death in human oral cancer CAL 27 cells through the reactive oxygen species production and caspase-dependent pathways and associated with beclin-1-induced cell autophagy","volume":"32","author":"Lien","year":"2017","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.biopha.2022.112727_bib60","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/jphp.12935","article-title":"Anticancer activity of tetrandrine by inducing pro-death apoptosis and autophagy in human gastric cancer cells","volume":"70","author":"Bai","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112727_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0498-9","article-title":"C-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.112727_bib62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbrc.2016.06.018","article-title":"Tetrandrine induces lipid accumulation through blockade of autophagy in a hepatic stellate cell line","volume":"477","author":"Miyamae","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2022.112727_bib63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/0310057X0903700112","article-title":"Survival after massive hydroxychloroquine overdose","volume":"37","author":"Gunja","year":"2009","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.biopha.2022.112727_bib64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.redox.2016.11.004","article-title":"Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons","volume":"11","author":"Redmann","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-018-0613-0","article-title":"Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo","volume":"18","author":"Yuan","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2022.112727_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.01087","article-title":"JNK and autophagy independently contributed to cytotoxicity of arsenite combined with tetrandrine via modulating cell cycle progression in human breast cancer cells","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112727_bib67","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/bph.13045","article-title":"Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21","volume":"172","author":"Mei","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112727_bib68","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1158\/1535-7163.MCT-12-0015","article-title":"Targeting the PI3K\/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors","volume":"11","author":"Ghadimi","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2022.112727_bib69","doi-asserted-by":"crossref","first-page":"10850","DOI":"10.1074\/jbc.M109.080796","article-title":"Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase","volume":"285","author":"Wu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.112727_bib70","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2022.112727_bib71","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.molcel.2013.12.004","article-title":"Ral and Rheb GTPase activating proteins integrate mTOR and GTPase signaling in aging, autophagy, and tumor cell invasion","volume":"53","author":"Martin","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2022.112727_bib72","first-page":"1","article-title":"The plant alkaloid tetrandrine inhibits metastasis via autophagy-dependent Wnt\/\u03b2-catenin and metastatic tumor antigen 1 signaling in human liver cancer cells","volume":"37","author":"Zhang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.112727_bib73","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3892\/or.2017.5988","article-title":"Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK\/mTOR pathway in human bladder cancer cells","volume":"38","author":"Kou","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2022.112727_bib74","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s13277-013-1293-y","article-title":"Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17","volume":"35","author":"Wu","year":"2014","journal-title":"Tumor Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib75","article-title":"A non-canonical MEK \/ ERK signaling pathway regulates","volume":"284","author":"Beclin","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.112727_bib76","first-page":"9719","article-title":"Activation of the SphK1\/ERK\/p-ERK pathway promotes autophagy in colon cancer cells","volume":"15","author":"Xu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2022.112727_bib77","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1002\/cam4.3356","article-title":"Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK\/ERK pathway","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.biopha.2022.112727_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0779-2","article-title":"Combination therapy with protein kinase inhibitor H89 and Tetrandrine elicits enhanced synergistic antitumor efficacy","volume":"37","author":"Yu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.112727_bib79","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1101\/gad.1199104","article-title":"Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome","volume":"18","author":"Corradetti","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2022.112727_bib80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1126\/science.1259472","article-title":"Differential regulation of mTORC1 by leucine and glutamine","volume":"347","author":"Jewell","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112727_bib81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ncomms8250","article-title":"LAPTM4b recruits the LAT1-4F2hc Leu transporter to lysosomes and promotes mTORC1 activation","volume":"6","author":"Milkereit","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.112727_bib82","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19079","article-title":"Mechanism of arginine sensing by CASTOR1 upstream of mTORC1","volume":"536","author":"Saxton","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.112727_bib83","doi-asserted-by":"crossref","first-page":"10403","DOI":"10.1007\/s13277-016-4950-0","article-title":"A novel derivative of tetrandrine (H1) induces endoplasmic reticulum stress-mediated apoptosis and prosurvival autophagy in human non-small cell lung cancer cells","volume":"37","author":"Lin","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib84","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1517\/14728222.2016.1101068","article-title":"Targeting autophagy and mitophagy for mitochondrial diseases treatment","volume":"20","author":"Villanueva Paz","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2022.112727_bib85","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1126\/science.1196371","article-title":"Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy","volume":"331","author":"Egan","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biopha.2022.112727_bib86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","article-title":"Targeting mTOR for cancer therapy","volume":"12","author":"Hua","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2022.112727_bib87","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cr.2015.133","article-title":"mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR","volume":"26","author":"Yin","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2022.112727_bib88","first-page":"15","article-title":"mTOR inhibitors at a glance","volume":"7","author":"Zheng","year":"2015","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112727_bib89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2019.03.006","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors","volume":"144","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2022.112727_bib90","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00280-017-3343-4","article-title":"TAK-228 (formerly MLN0128), an investigational dual TORC1\/2 inhibitor plus paclitaxel, with\/without trastuzumab, in patients with advanced solid malignancies","volume":"80","author":"Burris","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112727_bib91","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1158\/1535-7163.MCT-14-0711","article-title":"MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma","volume":"14","author":"Slotkin","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2022.112727_bib92","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10549-012-2298-8","article-title":"Investigational drug MLN0128, a novel TORC1\/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models","volume":"136","author":"G\u00f6kmen-Polar","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2022.112727_bib93","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02871-18","article-title":"Targeting mTOR with MLN0128 overcomes rapamycin and chemoresistant primary effusion lymphoma","volume":"10","author":"Caro-Vegas","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.biopha.2022.112727_bib94","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/1535-7163.MCT-15-0926","article-title":"Dual mTORC1\/2 inhibition as a novel strategy for the resensitization and treatment of platinum-resistant ovarian cancer","volume":"15","author":"Musa","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2022.112727_bib95","doi-asserted-by":"crossref","first-page":"33064","DOI":"10.18632\/oncotarget.25869","article-title":"mTORC1\/2 inhibition re-sensitizes platinum-resistant ovarian cancer by disrupting selective translation of DNA damage and survival mRNAs","volume":"9","author":"David-West","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.112727_bib96","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1158\/1535-7163.MCT-18-0260","article-title":"MTORC1\/2 and protein translation regulate levels of Chk1 and the sensitivity to CHK1 inhibitors in Ewing sarcoma cells","volume":"17","author":"Koppenhafer","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2022.112727_bib97","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-13-2136","article-title":"The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cells","volume":"20","author":"Hayman","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2022.112727_bib98","doi-asserted-by":"crossref","first-page":"113874","DOI":"10.18632\/oncotarget.23022","article-title":"Evaluation of the combination of the dual m-TORC1\/2 inhibitor vistusertib (AZD2014) and paclitaxel in ovarian cancer models","volume":"8","author":"Te Fong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.112727_bib99","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ygyno.2012.06.032","article-title":"Metformin impairs the growth of liver kinase B1-intact cervical cancer cells","volume":"127","author":"Xiao","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.biopha.2022.112727_bib100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14305","article-title":"Molecular regulation of autophagy machinery by mTOR-dependent and -independent pathways","volume":"1467","author":"Al-Bari","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2022.112727_bib101","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1042\/BST20130134","article-title":"Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers","volume":"41","author":"Sarkar","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2022.112727_bib102","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00029.2002","article-title":"The calpain system","volume":"83","author":"Goll","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2022.112727_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/nchembio.79","article-title":"Novel targets for Huntington\u2019s disease in an mTOR- independent autophagy pathway","author":"Williams","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib104","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1211\/0022357022458","article-title":"Antihypertensive and anti-arrhythmic effects of an extract of Radix Stephaniae Tetrandrae in the rat","volume":"56","author":"Yu","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112727_bib105","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4161\/auto.4240","article-title":"AMP-activated protein kinase: a universal regulator of autophagy?","volume":"3","author":"H\u00f8yer-Hansen","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2022.112727_bib106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ceca.2018.09.005","article-title":"Nonlinear relationship between ER Ca 2+ depletion versus induction of the unfolded protein response, autophagy inhibition, and cell death","volume":"76","author":"Szalai","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.biopha.2022.112727_bib107","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/aps.2013.5","article-title":"Application and interpretation of current autophagy inhibitors and activators","volume":"34","author":"Yang","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2022.112727_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.578418","article-title":"The double-edge sword of autophagy in cancer: from tumor suppression to pro-tumor activity","volume":"10","author":"Chavez-Dominguez","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2022.112727_bib109","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrm3735","article-title":"Self-consumption: the interplay of autophagy and apoptosis","volume":"15","author":"Mari\u00f1o","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib110","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/aps.2013.23","article-title":"Autophagy modulation as a target for anticancer drug discovery","volume":"34","author":"Li","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2022.112727_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2018.00137","article-title":"Beclin 1 phosphorylation - at the center of autophagy regulation","volume":"6","author":"Menon","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib112","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.4161\/auto.22110","article-title":"Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells","volume":"8","author":"Zou","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2022.112727_bib113","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.molcel.2008.06.001","article-title":"JNK1-Mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy","volume":"30","author":"Wei","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.biopha.2022.112727_bib114","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/onc.2008.24","article-title":"FOXOs, cancer and regulation of apoptosis","volume":"27","author":"Fu","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2022.112727_bib115","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1074\/jbc.M112.442061","article-title":"Transcription factor Foxo3a prevents apoptosis by regulating calcium through the apoptosis repressor with caspase recruitment domain","volume":"288","author":"Lu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2022.112727_bib116","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/tox.22053","article-title":"Tetrandrine induces apoptosis Via caspase-8, -9, and -3 and poly (ADP ribose) polymerase dependent pathways and autophagy through beclin-1\/ LC3-I, II signaling pathways in human oral cancer HSC-3 cells","volume":"31","author":"Yu","year":"2016","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.biopha.2022.112727_bib117","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/1534735421996822","article-title":"Resuming sensitivity of tamoxifen-resistant breast cancer cells to tamoxifen by tetrandrine","volume":"20","author":"Wang","year":"2021","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.biopha.2022.112727_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.7117","article-title":"Autophagy inhibition enhances anti-pituitary adenoma effect of tetrandrine","author":"Lyu","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2022.112727_bib119","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2022.112727_bib120","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00018-018-2973-y","article-title":"Targeting autophagy using metallic nanoparticles: a promising strategy for cancer treatment","volume":"76","author":"Cordani","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2022.112727_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biopha.2022.112727_bib122","doi-asserted-by":"crossref","first-page":"24604","DOI":"10.18632\/oncotarget.8360","article-title":"Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells","volume":"7","author":"tao Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2022.112727_bib123","first-page":"1","article-title":"Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.112727_bib124","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/08982104.2020.1748647","article-title":"Enhanced antitumour efficiency of R8GD-modified epirubicin plus tetrandrine liposomes in treatment of gastric cancer via inhibiting tumour metastasis","volume":"31","author":"Li","year":"2021","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.biopha.2022.112727_bib125","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/1061186X.2020.1777419","article-title":"Dual variable of drug loaded micelles in both particle and electrical charge on gastric cancer treatment","volume":"28","author":"ying Li","year":"2020","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biopha.2022.112727_bib126","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1021\/acsami.9b17363","article-title":"Novel \u201ccarrier-Free\u201d nanofiber codelivery systems with the synergistic antitumor effect of paclitaxel and tetrandrine through the enhancement of mitochondrial apoptosis","volume":"12","author":"Li","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.biopha.2022.112727_bib127","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1166\/jbn.2016.2293","article-title":"Characterization of the uptake efficiency and cytotoxicity of tetrandrine-loaded poly(N-vinylpyrrolidone)-Block-Poly(\u03f5-caprolactone) (PVP-b-PCL) nanoparticles in the A549 lung adenocarcinoma cell line","volume":"12","author":"Xu","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.biopha.2022.112727_bib128","first-page":"1893","article-title":"Effect of inductive heating on drug release of tetrandrine-loaded PLGA magnetic nanoparticles","volume":"50","author":"Chen","year":"2015","journal-title":"Chin. Pharm. J."},{"key":"10.1016\/j.biopha.2022.112727_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7683791","article-title":"Characterization and evaluation of a folic acid receptor-targeted norcantharidin\/tetrandrine dual-drug loaded delivery system","volume":"2019","author":"Xiong","year":"2019","journal-title":"J. Nanomater."},{"key":"10.1016\/j.biopha.2022.112727_bib130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10717544.2019.1573861","article-title":"Study on preparation, characterization and multidrug resistance reversal of red blood cell membrane-camouflaged tetrandrine-loaded PLGA nanoparticles","volume":"26","author":"Que","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2022.112727_bib131","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3109\/03639045.2013.795582","article-title":"Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies","volume":"40","author":"Li","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2022.112727_bib132","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/bph.13045","article-title":"Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21","volume":"172","author":"Mei","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.112727_bib133","doi-asserted-by":"crossref","first-page":"10403","DOI":"10.1007\/s13277-016-4950-0","article-title":"A novel derivative of tetrandrine (H1) induces endoplasmic reticulum stress-mediated apoptosis and prosurvival autophagy in human non-small cell lung cancer cells","volume":"37","author":"Lin","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.biopha.2022.112727_bib134","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1111\/bph.14031","article-title":"Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy-mediated differentiation","volume":"174","author":"Liu","year":"2017","journal-title":"Br. J. Pharmacol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:35:49Z","timestamp":1781764549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":134,"alternative-id":["S0753332222001159"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112727","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy and cancer: Can tetrandrine be a potent anticancer drug in the near future?","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112727"}}